Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

107.10EUR
17 Apr 2014
Price Change (% chg)

€-0.05 (-0.05%)
Prev Close
€107.15
Open
€106.85
Day's High
€107.50
Day's Low
€106.05
Volume
345,210
Avg. Vol
445,284
52-wk High
€120.60
52-wk Low
€87.03

FREG.DE

Chart for FREG.DE

About

Fresenius SE & Co KGaA is a health care company. It operates in the healthcare sector and offers products and services for dialysis, hospitals and outpatient medical care. It focuses on the hospital operations and offers engineering and services for hospitals and other health care facilities. The Company’s operating segments... (more)

Overall

Beta: 0.43
Market Cap (Mil.): €19,259.16
Shares Outstanding (Mil.): 179.82
Dividend: 1.25
Yield (%): 1.17

Financials

  FREG.DE Industry Sector
P/E (TTM): 19.52 96.12 33.35
EPS (TTM): 5.49 -- --
ROI: 8.49 5.33 18.92
ROE: 12.17 5.28 19.68
Search Stocks

Rhoen CFO says eyeing acquisition of larger hospitals - paper

FRANKFURT, April 10 - German hospitals operator Rhoen-Klinikum, which has sold about two thirds of its assets to peer Fresenius, is looking for takeover targets to focus on larger hospital complexes.

10 Apr 2014

Exclusive: Nestle and Fresenius home in on Danone Medical - sources

LONDON/FRANKFURT - The field of bidders for Danone's Medical Nutrition business has narrowed to German healthcare group Fresenius and Swiss food company Nestle, two people familiar with the process told Reuters on Friday.

04 Apr 2014

Fresenius, Nestle sole bidders for Danone Medical Nutrition

LONDON/FRANKFURT, April 4 - German diversified healthcare group Fresenius and Swiss food giant Nestle are the only bidders left for Danone's Medical Nutrition unit, two people familiar with the process told Reuters on Friday.

04 Apr 2014

Nestle among four firms eyeing Danone's Medical Nutrition: report

PARIS - Swiss food giant Nestle and diversified German healthcare group Fresenius are among the four groups that have shown interest in buying the Medical Nutrition unit of France's Danone , daily Les Echos said on Thursday.

21 Mar 2014

CORRECTED-UPDATE 1-Nestle among four firms eyeing Danone's Medical Nutrition -report

(Corrects company name in 2nd paragraph to Danone, from Nestle)

21 Mar 2014

German hospitals group Sana says large takeovers possible in future

FRANKFURT, March 21 - Sana Kliniken AG, the third-largest private-sector hospitals operator in Germany, has trained its sights on major rivals as potential takeover targets in the long term to keep up with industry leader Fresenius .

21 Mar 2014

Nestle among four firms eyeing Danone's Medical Nutrition: report

PARIS - Swiss food giant Nestle and diversified German healthcare group Fresenius are among the four groups that have shown interest in buying the Medical Nutrition unit of France's Danone , daily Les Echos said on Thursday.

20 Mar 2014

UPDATE 1-Nestle among four firms eyeing Danone's Medical Nutrition -report

* Other candidates include Fresenius, EQT fund, unamed company -Les Echos

20 Mar 2014

Nestle among four firms eyeing Danone's Medical Nutrition-report

PARIS, March 20 - Swiss food giant Nestle and diversified German healthcare group Fresenius are among the four groups who have shown interest in buying the Medical Nutrition unit of France's Danone, daily Les Echos said on Thursday.

20 Mar 2014

Fitch Affirms Fresenius at 'BB+'; Outlook Positive

(The following statement was released by the rating agency) LONDON, March 20 (Fitch) Fitch Ratings has affirmed Fresenius SE & Co. KGaA's (FSE) and subsidiary Fresenius Medical Care AG & Co. KGaA's (FMC; together Fresenius) Long-term Issuer Default Ratings (IDR) at 'BB+'. The ratings have been removed from Rating Watch Evolving (RWE) on which they were placed since 13 September 2013. The Outlook on the IDRs is Positive. A full list of rating actions is provided below. The affirmation of the

20 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Finlabo SIM Spa
$10.00
Provider: GlobalData
$125.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks